Uncategorized
Abbott reports $5.1 billion in third-quarter worldwide sales
Abbott reported worldwide sales revenues of $5.1 billion from continuing operations in its third quarter, marking a 6.7% increase on an operational basis and a 5.8% increase on a reported basis compared with the third quarter of 2013.Third-quarter diluted earnings per share increased by 12.7% from the previous year to $0.62, excluding certain items according to a company press release. This growth was above the previous guidance range of $0.59 to $0.61 and includes results from the developed markets branded generics pharmaceuticals business.